Management of Episodic Migraine in Children and Adolescents: a Practical Approach
- 418 Downloads
Purpose of Review
Episodic migraine is very common in children and adolescents, seen by primary care and specialists. In kids, this can greatly affect quality of life, including significant disability, specifically in terms of missed school and other activities. The goal of this paper is to give an overview of the most up-to-date thoughts on episodic migraine in the pediatric population.
Current options for both abortive and preventative treatments in kids, as well as specific non-pharmacological and lifestyle management recommendations for children, will be reviewed, as well as options for status migrainosus in the pediatric patient.
Migraine pathophysiology is similar in adults and children with episodic migraine, but the approach to the management needs to be modified and adjusted in kids. Recognizing the impact on quality of life especially with regard to school and knowing appropriate treatment options can improve treatment and decrease the disability from this disorder.
KeywordsMigraine Pediatric migraine Pediatric episodic migraine Lifestyle management in pediatric migraine Triptans Non-pharmacological treatment modalities in pediatric migraine
Compliance with Ethical Standards
Conflict of Interest
Reena Gogia Rastogi is a sub-investigator for Avanir. Clarimar Borrero-Mejias, Carolyn Hickman, Kara Stuart Lewis, and Robert Little each declare no potential conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 11.• Szperka CL, Gelfand AA, Hershey AD. Patterns of use of peripheral nerve blocks and trigger point injections for pediatric headache: results of a survey of the American Headache Society Pediatric and Adolescent Section. Headache. 2016;56(10):1597–607. This paper queried pediatric headache providers from the Pediatric and Adolescent Section of the American Headache Society as to the use of nerve blocks in their clinical practice, and was unique in capturing data from this small group. CrossRefGoogle Scholar
- 12.• Kaye R, et al. SPG blockade reported as a safe and effective migraine headache treatment for children. Presented at the Society of Interventional Radiology Annual Scientific Meeting in March 2017. Appl Radiol. 2017. This paper is unique in presenting extensive clinical cases of SPG blocks used in children for acute migraine treatment. Google Scholar
- 15.VanderPluym J. 2018. Retrieved from https://americanmigrainefoundation.org/understanding-migraine/migraine-stroke-heart-disease/Strategies to Avoid Emergency Department Visits for Migraine on May 21, 2018.
- 16.Fernandez-de-Las-Penas C, Hernandez-Barera V, Carrasco-Garrido V, Alonso-Blanco C, Palacious-Cena D, Jimenez-Sanchez S, et al. Population-based study of migraine in Spanish adults: relation to socio-demographic factors, lifestyle and comorbidity with other conditions. Headache. 2010;11(2):1–13.Google Scholar
- 17.•• Paruthi S, Brooks LJ, D’Ambrosio C, Hall WA, Kotagal S, Lloyd RM, et al. Recommended amount of sleep for pediatric populations: a consensus statement of the American Academy of Sleep Medicine. J Clin Sleep Med. 2016;12(6):785–6 An excellent consensus statement on the amount of sleep needed for children and adolescents to promote optimal health.CrossRefGoogle Scholar
- 20.Millichap JG, Yee MM. The diet factor in pediatric and adolescent migraine. Neurology. 2003;28(1):9–15.Google Scholar
- 27.Campbell JK, Penzien DB, Wall EM. Evidence-based guidelines for migraine headache: behavioral and physical treatments. US Headache Consortium 2000. Available at https://search.pedio.org.au/search-results/record-detail/9764. Accessed March 7, 2018.
- 35.Lewis DW, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S, et al. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63(12):2215–24.CrossRefGoogle Scholar
- 37.Lewis D, Winner P, Saper J, et al. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics. 2009;123:924–34. https://doi.org/10.1542/peds.2008-0642.CrossRefPubMedGoogle Scholar
- 39.•• Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, et al. Trial of amitriptyline, topiramate, and placebo for pediatric migraine. NEJM. 2016. https://doi.org/10.1056/NEJMoa1610384. This article presented the unexpected results of a very robust study of prophylactic medications in pediatric migraine and showed the power of the placebo response in pediatric studies. CrossRefGoogle Scholar
- 40.• Kacperski J, Bazarsky A. New developments in the prophylactic drug treatment of pediatric migraine: what is new in 2017 and where does it leave us? Curr Pain Headache Rep. 2017;21:38. https://doi.org/10.1007/s11916-017-0638-4. This article delves deeper into the results and implications of the Childhood and Adolescent Migraine Prevention Study (CHAMP) and discusses how this will affect future studies in pediatric headache. CrossRefPubMedGoogle Scholar
- 42.Caruso JM, Brown WD, Exil G, Gascon GG. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache. 2000;40:672–6. https://doi.org/10.1046/j.1526-4610.2000.040008672.CrossRefPubMedGoogle Scholar
- 45.Rajdev SK, Wassmer E, Agrawal S, Smith M, Philip SG, Gupta R. Efficacy and tolerability of the use gabapentin for migraine prophylaxis in children. Arch Dis Child. 2012;1997. https://doi.org/10.1136/archdischild-2012-301885.336.CrossRefGoogle Scholar
- 46.Mathew NT, Rapoport A, Saper J, Magnus L, Klapper J, Ramadan N, et al. Efficacy of gabapentin in migraine prophylaxis. Headache. 2001;41:119–28. https://doi.org/10.1046/j.1526-4610.2001.111006119.CrossRefPubMedGoogle Scholar
- 49.Eidlitz-Markus T, Dlugatch Y, Haimi-Cohen Y, Goldberg-Stern H, Zeharia A. Nonpharmacologic treatment of migraine with low-dose propranolol or amitriptyline. Pediatr Neurol. 2012;46(6):345–9. https://doi.org/10.1016/j.pediatrneurol.2012.03.017.CrossRefPubMedGoogle Scholar
- 51.Silberstein SD, Holland S, Freitag F, et al. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78:1337–45.CrossRefGoogle Scholar
- 66.• Sheridan DC, Meckler GD. Inpatient pediatric migraine treatment: does choice of abortive therapy affect length of stay? J Pediatr. 2016;179:211–5. This article clarifies that the use of opioids as part of an inpatient treatment plan for pediatric migraine actually leads to longer stays. CrossRefGoogle Scholar
- 67.• Leung S, Bulloch B, Young C, Yonker M, Hostetler M. Effectiveness of standardized combination therapy for migraine treatment in the pediatric emergency department. Headache. 2013;53:491–197. Not new, but still one of the most clear descriptions of an emergency department protocol for migraine treatment in a children’s hospital. CrossRefGoogle Scholar